Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
25 studies found for:    " January 25, 2012":" February 24, 2012"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Show Display Options
RSS Create an RSS feed from your search for:
" January 25, 2012":" February 24, 2012"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Completed Medical Marijuana Use in HIV+ Patients: Probability Survey
Condition: HIV Positive
Intervention:
2 Completed Use of Incentives to Engage Drug Users in HIV Therapy
Condition: HIV Infection
Intervention: Other: monetary reinforcer
3 Completed Study Comparing Two Alternatives of Antiretroviral Therapy as Post-exposure Prophylaxis to HIV-1:FOVIR+EMTRICITABINA + LOPINAVIR/RITONAVIR VS TENOFOVIR+EMTRICITABINA + MARAVIROC (MARAVI-PEP)
Condition: HIV Infection
Interventions: Drug: Tenofovir, emtricitabine, maraviroc;   Drug: Tenofovir, emtricitabine, lopinavir/r
4 Active, not recruiting Safety and Efficacy Trial of a Dapivirine Vaginal Matrix Ring in Healthy HIV-Negative Women
Condition: HIV Infections
Intervention: Drug: Placebo Vaginal Ring
5 Active, not recruiting Medical Marijuana Use in HIV+ Patients Prospective Cohort Study
Conditions: HIV Positive;   Marijuana Smoking
Intervention:
6 Recruiting Testing and Linkage to Care for Injecting Drug Users in Kenya
Condition: HIV Infection
Intervention: Behavioral: Point of Care CD4 count and peer case management
7 Completed
Has Results
Open-Label Pilot Study to Evaluate Switching From a Regimen Consisting of Raltegravir Plus Emtricitabine/Tenofovir DF Fixed-Dose Combination to the Elvitegravir/Cobicistat/Emtricitabine/Tenofovir DF Single-Tablet Regimen in Virologically Suppressed, HIV-1 Infected Patients
Conditions: Acquired Immunodeficiency Syndrome;   HIV Infections
Intervention: Drug: Stribild
8 Active, not recruiting Four-Arm Randomized Control Trial of Brief MI Versus Couples-Based HIV/STI Prevention in South Africa
Condition: HIV Prevention
Interventions: Other: Testing and Counseling;   Behavioral: Brief Motivational Interview (BMI);   Behavioral: Integrated Family and Cognitive Behavioral Therapy
9 Completed
Has Results
ACE Inhibitors to Decrease Lymphoid Fibrosis in Antiretroviral-Treated, HIV-infected Patients: A Pilot Study
Condition: HIV
Interventions: Drug: Lisinopril;   Drug: Placebo
10 Active, not recruiting Vitamin D Supplementation in HIV Youth
Condition: HIV+
Intervention: Drug: Vitamin D3
11 Active, not recruiting Efficacy of Pegylated Interferon Plus Ribavirin Plus Nitazoxanide in HCV Genotype 4 and HIV Coinfection
Conditions: HCV Coinfection;   HIV Infection
Intervention: Drug: Nitazoxanide
12 Terminated Safety and Acceptability Study of Non-occupational Prophylaxis (PEP) Following Potential Exposure to HIV
Condition: HIV
Interventions: Drug: 3 drug regimen: Tenofovir DF and Emtricitabine; Ritonavir-boosted Atazanavir;   Drug: Ritonavir, Atazanavir, Truvada
13 Recruiting Reversing Tissue Fibrosis to Improve Immune Reconstitution in HIV
Conditions: HIV Infection;   HIV Infections
Interventions: Drug: Losartan;   Drug: Placebo
14 Recruiting Dolutegravir Expanded Access Study
Condition: Infection, Human Immunodeficiency Virus
Intervention: Drug: Dolutegravir
15 Unknown  Safety of Reduced Dose Zidovudine (AZT) Compared With Standard Dose AZT in Antiretroviral-naïve HIV-infected Patients
Conditions: HIV;   Zidovudine Adverse Reaction
Intervention: Drug: Zidovudine
16 Completed Early Access to Low-dose Ritonavir (TMC114/r) and Other Antiretrovirals (ARVs) for Treatment-naive or Early Treatment Experienced in HIV-1 Patients
Condition: HIV-1
Intervention: Drug: TMC114/ritonavir
17 Completed Effects of Losartan and Antiretroviral Regimen Containing Raltegravir in Fibrosis Inflammation Mediators, Cardiovascular Risk and Neurocognitive Disorders in HIV Infected Patients Previously Effectively Treated
Condition: HIV-1 Infection
Interventions: Drug: EFV/FTC/TDF + Losartan;   Drug: EFV/FTC/TDF;   Drug: FTC/TDF + MK-0518;   Drug: FTC/TDF+MK-0518+Losartan
18 Active, not recruiting Gender-Specific Combination HIV Prevention for Youth in High Burden Settings (MP3-Youth)
Conditions: HIV;   Adolescent Behavior;   Gender
Interventions: Other: Male-Specific Intervention Package;   Other: Female-Specific Intervention Package;   Drug: Pre-Exposure Prophylaxis (Females);   Behavioral: Cash Transfer Cohort (Females)
19 Completed
Has Results
Intervention to Retain HIV-positive Patients in Medical Care
Condition: Primary Care Appointment Keeping
Interventions: Behavioral: Enhanced contact plus behavioral skills;   Behavioral: Enhanced contact only;   Behavioral: Standard of Care
20 Completed Methadone Maintenance and HIV Prevention: A Window of Opportunity in China
Conditions: Capacity Building;   Drug Use;   HIV/AIDS
Intervention: Behavioral: MMT CARE

   Previous Page Studies Shown (1-20) Next Page (21-25) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.